| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| OPIANT PHARMACEUTICALS, INC. | Director, 10%+ Owner | Common Stock, par value $0.001 per share | 0 | $20.00 | 02 Mar 2023 | Direct | |
| OPIANT PHARMACEUTICALS, INC. | Director, 10%+ Owner | Common Stock | 0 | $20.00 | 02 Mar 2023 | Indirect | |
| OPIANT PHARMACEUTICALS, INC. | Director, 10%+ Owner | Options | 0 | 02 Mar 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| OPNT | OPIANT PHARMACEUTICALS, INC. | 02 Mar 2023 | 6 | -$1,803,400 | 4 | Director, 10%+ Owner | 03 Mar 2023, 08:10 |
| OPNT | OPIANT PHARMACEUTICALS, INC. | 13 Jun 2022 | 3 | -$149,188 | 4 | Director, 10%+ Owner | 15 Jun 2022, 16:30 |
| OPNT | OPIANT PHARMACEUTICALS, INC. | 09 Jun 2022 | 1 | -$96,726 | 4 | Director, 10%+ Owner | 13 Jun 2022, 16:05 |
| OPNT | OPIANT PHARMACEUTICALS, INC. | 06 Jun 2022 | 2 | -$109,771 | 4 | Director, 10%+ Owner | 08 Jun 2022, 16:39 |
| OPNT | OPIANT PHARMACEUTICALS, INC. | 02 Jun 2022 | 2 | -$274,623 | 4 | Director, 10%+ Owner | 06 Jun 2022, 16:57 |
| OPNT | OPIANT PHARMACEUTICALS, INC. | 23 Aug 2021 | 9 | -$1,606,674 | 4 | Director, 10%+ Owner | 25 Aug 2021, 16:38 |